22-31619755-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001326411.2(PISD):c.1087G>A(p.Val363Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,614,172 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V363L) has been classified as Likely benign.
Frequency
Consequence
NM_001326411.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PISD | NM_001326411.2 | c.1087G>A | p.Val363Ile | missense_variant | 8/8 | ENST00000439502.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PISD | ENST00000439502.7 | c.1087G>A | p.Val363Ile | missense_variant | 8/8 | 1 | NM_001326411.2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152212Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000956 AC: 24AN: 251138Hom.: 2 AF XY: 0.000140 AC XY: 19AN XY: 135816
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461842Hom.: 6 Cov.: 32 AF XY: 0.0000963 AC XY: 70AN XY: 727230
GnomAD4 genome AF: 0.000112 AC: 17AN: 152330Hom.: 2 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74490
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PISD protein function. ClinVar contains an entry for this variant (Variation ID: 1493535). This variant has not been reported in the literature in individuals affected with PISD-related conditions. This variant is present in population databases (rs199697700, gnomAD 0.07%). This sequence change replaces valine with isoleucine at codon 363 of the PISD protein (p.Val363Ile). The valine residue is weakly conserved and there is a small physicochemical difference between valine and isoleucine. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at